Allergies
Cytos Biotech's Allergy Drug Showing Promise in Clinical Trials
Filed in archive Allergy: Research and Development by ruth on July 4, 2007
Cytos Biotech's Allergy Drug Showing Promise in Clinical Trials
Cytos Biotechnology AG's CYT003-QbG10 is an immunotherapeutic product candidate currently in development for the treatment of allergic diseases. This allergy product have previously shown strong efficacy in conjunction with a specific allergen in patients with house dust mite allergy.

Now, in a Phase IIa study in patients with mild to moderate atopic dermatitis, CYT003-QbG10 has demonstrated safety and was generally well tolerated.

According to Dr. Wolfgang Renner, CEO of Cytos Biotechnology:

"While CYT003-QbG10 has shown strong efficacy in conjunction with a specific allergen in patients with house dust mite allergy, we are still in the process of identifying the best treatment parameters for its application as a monotherapy.

This monotherapy has achieved first promising results in grass pollen and also house dust mite allergy. For the latter indication we are now testing higher doses of the product candidate. Based on the outcome of these studies we will then also consider the path forward in atopic dermatitis."


You can read the press release from Cytos (a pdf file) or the Forbes news report.



Permalink: Cytos Biotech's Allergy Drug Showing Promise in Clinical Trials
Tags: house  dust  mite  allergy  Cytos  Biotechnology  allergy  immunotherapy  atopic  dermatitis  allergies  promis 
Trackback: http://publish.creative-weblogging.com/publish/mt-tb.pl/79218
img Addthis img Ask img Blinklist img del.icio.us img Digg img Fark img Facebook img Google img Lycos img Ma.gnolia Add this page to Mister Wong Mr Wong img Netscape img Netvousz img Newsvine img Reddit img StumbleUpon img Slashdot img Tailrank img Technorati img Wink img Yahoo

Vote for Cytos Biotech's Allergy Drug Showing Promise in Clinical Trials:

  • Currently 7.33/10
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
Rating: 7.33 out of 3 vote(s) cast.
 
Subscribe
Share It
Popular posts from our other blogs:
RSSrss
See all blog subscribe options
Google google
What is RSS?
Yahoo! yahoo
Addthis Subscribe using any feed reader!
Bloglines Bloglines
Newsletter

TwitterFollow us on Twitter!